November, 10, 2016

Tufts Center for the Study of Drug Development names new Administrative Manager

Sundé Watson Daniels will support the Director of Tufts CSDD, Dr. Ken Kaitin, in the design and implementation of all CSDD activities and operations, with a focus on fundraising and sponsorship, and outreach to various industry stakeholders  

"Sundé is a great fit for CSDD and specifically the Administrative Manager position because of her background in the pharma industry, academia, and business," says Ken Kaitin, Director of CSDD. "Her knowledge and insights will be invaluable in supporting and furthering the Center's mission. I'm thrilled to welcome Sundé to the CSDD staff."  

Ms. Daniels adds, "I'm excited to join CSDD. I believe that we are entering a new era for biopharmaceutical innovation. It's an honor to have this opportunity to work for a world-renowned academic research center whose mission is to provide unbiased information about drug development through strategic path-breaking research."

Sundé comes to Tufts CSDD from Harvard University, where she was most recently Administrator for the Department of African and African American Studies.

Ms. Daniels holds a BS in Biochemistry from Eastern University and an MBA-with a concentration in Pharmaceutical Business-from University of the Sciences of Philadelphia. She is also a Notary Public and Certified NFL Contract Advisor.


About the Tufts Center for the Study of Drug Development

The Tufts Center for the Study of Drug Development ( at Tufts University provides strategic information to help drug developers, regulators, and policy makers improve the quality and efficiency of pharmaceutical development, review, and utilization. Tufts CSDD, based in Boston, conducts a wide range of in-depth analyses on pharmaceutical issues and hosts symposia, workshops, and public forums, and publishes Tufts CSDD Impact Reports, a bi-monthly newsletter providing analysis and insight into critical drug development issues.